Hong Kong vs Montenegro: Life science patents granted, by technology
Hong Kong
54 patents
in 2020
Montenegro
58 patents
in 2021
Hong Kong rank
21st
Montenegro rank
20th
Life science patents granted, by technology over time
- Hong Kong
- Montenegro
How they compare
Montenegro currently reports 58 patents against 54 patents in Hong Kong, a difference of 4 patents.
That makes Montenegro's figure about 1.1 times Hong Kong's.
The two have swapped places 1 time across 15 shared years of data; in 2005 it was Hong Kong ahead.
Hong Kong ranks 21st and Montenegro ranks 20th of 65 countries.
Across the 3 decades both report, Hong Kong averaged higher in 1 and Montenegro in 2.
Head to head by decade
| Decade | Hong Kong | Montenegro | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 127.25 patents | 5.75 patents | 121.5 patents | Hong Kong |
| 2010s | 10.7 patents | 89.1 patents | 78.4 patents | Montenegro |
| 2020s | 54 patents | 123 patents | 69 patents | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher life science patents granted, by technology, Hong Kong or Montenegro?
- Montenegro, at 58 patents against 54 patents in Hong Kong as of 2021.
- What is the difference in life science patents granted, by technology between Hong Kong and Montenegro?
- 4 patents, with Montenegro ahead.
- How many years of comparable data are there for Hong Kong and Montenegro?
- 15 years are reported by both, from 2005 to 2020.
- How do Hong Kong and Montenegro rank globally for life science patents granted, by technology?
- Hong Kong ranks 21st and Montenegro ranks 20th of 65 countries.
- Where does this data come from?
- World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.